Drew Goldstein is the Co-Founder of Ephemeral Technologies, a company founded to accelerate end-to-end drug development and delivery. Ephemeral is developing an integrated AI, software, and robotics platform by working backwards from high-value problems identified by an initial cohort of pharma companies, biotech startups, governmental organizations, and contract research organizations (CROs). Before Ephemeral, Goldstein built and ran Palantir’s healthcare business, which grew from 0 to $300M+ ARR.